Steroids After Spine Fusion Surgery

Part of paid clinical trials in Portland, Oregon.

Sponsor
Oregon Health and Science University
Study ID
NCT04568837
Phase
PHASE4
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Spine Fusion

Eligibility Criteria

Sex
ALL
Age
50 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Prednisone 20 Mg — DRUG
    20 mg of Prednisone or 1 mL of 4 mg/mL Dexamethasone Sodium Phosphate will be administered each day for participants in the intervention group

Study Details

This trial studies how well low-dose postoperative corticosteroids (FDA approved) affect patient outcomes (patient reported outcomes, pain medication use, length of stay, major complications, and time to first bowel movement) after thoracic and/or lumbar spine fusion surgery.

Key Dates

Start date
Mar 1, 2025
Status verified
Apr 2024
Primary completion
Oct 6, 2026
Completion
Oct 6, 2026

Study Design

Enrollment
420 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Corticosteroid
    Participants in this group will receive a daily dose of corticosteroids on postoperative day one and two after spine fusion surgery
  • No Intervention: Control
    Participants in this group will receive no steroids on postoperative day one and two after spine fusion surgery.

Primary Outcome Measure

Morphine equivalent pain medication use over the length of hospitalization [ Time Frame: From postoperative admission to discharge, up to 4 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Oregon Health and Science UniversityPortlandOregon97239
Spencer J Smith, BS
503-828-7136

Find similar trials in Portland, OR

Related Studies